{"id":205848,"date":"2024-06-03T00:00:00","date_gmt":"2024-06-03T20:14:34","guid":{"rendered":"https:\/\/www.mdbriefcase.com\/?post_type=eb_course&#038;p=205848"},"modified":"2024-12-19T16:38:01","modified_gmt":"2024-12-19T21:38:01","slug":"traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures","status":"publish","type":"eb_course","link":"https:\/\/www.mdbriefcase.com\/fr\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/","title":{"rendered":"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures"},"content":{"rendered":"<p dir=\"ltr\" style=\"text-align: left\">Le cancer de la t\u00eate et du cou occupe la 6e place parmi les cancers les plus fr\u00e9quents au Canada. La majorit\u00e9 des cancers qui touchent la t\u00eate et le cou (\u223c90 %) sont du type carcinome spinocellulaire (aussi appel\u00e9 carcinome squameux, carcinome \u00e9pidermo\u00efde ou carcinome malpighien), et la plupart des patients (\u223c60 %) re\u00e7oivent un diagnostic de carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA). Dans les cas de cancer de la cavit\u00e9 buccale et de cancer du larynx class\u00e9s T4, la chirurgie est pr\u00e9f\u00e9rable. Dans les cas de cancer oropharyng\u00e9, la chirurgie est une option lorsque le cou est jug\u00e9 cliniquement exempt de cancer, afin d&#039;\u00e9viter la radioth\u00e9rapie. Les cancers de l&#039;oropharynx caus\u00e9s par le virus du papillome humain (VPH) repr\u00e9sentent une entit\u00e9 distincte des cancers oropharyng\u00e9s non en lien avec le VPH. En tant qu&#039;approche visant \u00e0 \u00e9conomiser les organes, la chimioradioth\u00e9rapie est souvent adopt\u00e9e en tant que traitement de premier choix dans les cas de cancer oropharyng\u00e9. Des travaux de recherche et des \u00e9tudes cliniques actuellement en cours continuent d&#039;enrichir nos connaissances sur les CETC-LA et sur les options de traitement pharmaco-th\u00e9rapeutiques, offrant la possibilit\u00e9 de raffiner les pratiques et d&#039;am\u00e9liorer les r\u00e9sultats pour les patients.\n<\/p>\n<hr>\n<p dir=\"ltr\" style=\"text-align: left\">Ce programme a re\u00e7u une subvention \u00e9ducative ou un soutien en nature d&#039;EMD Serono. <\/p>","protected":false},"featured_media":526518,"comment_status":"closed","ping_status":"closed","template":"","eb_course_cat":[],"class_list":["post-205848","eb_course","type-eb_course","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase\" \/>\n<meta property=\"og:description\" content=\"Le cancer de la t\u00eate et du cou occupe la 6e place parmi les cancers les plus fr\u00e9quents au Canada. La majorit\u00e9 des cancers qui touchent la t\u00eate et le cou (\u223c90 %) sont du type carcinome spinocellulaire (aussi appel\u00e9 carcinome squameux, carcinome \u00e9pidermo\u00efde ou carcinome malpighien), et la plupart des patients (\u223c60 %) re\u00e7oivent [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mdbriefcase.com\/fr\/cours\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/\" \/>\n<meta property=\"og:site_name\" content=\"MDBriefCase\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-19T21:38:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/\",\"name\":\"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase\",\"isPartOf\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg\",\"datePublished\":\"2024-06-03T20:14:34+00:00\",\"dateModified\":\"2024-12-19T21:38:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.mdbriefcase.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Course\",\"item\":\"https:\/\/www.mdbriefcase.com\/courses\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#website\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"name\":\"MDBriefCase\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mdbriefcase.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#organization\",\"name\":\"MDBriefCase\",\"url\":\"https:\/\/www.mdbriefcase.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"contentUrl\":\"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp\",\"width\":190,\"height\":36,\"caption\":\"MDBriefCase\"},\"image\":{\"@id\":\"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mdbriefcase.com\/fr\/cours\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/","og_locale":"fr_CA","og_type":"article","og_title":"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase","og_description":"Le cancer de la t\u00eate et du cou occupe la 6e place parmi les cancers les plus fr\u00e9quents au Canada. La majorit\u00e9 des cancers qui touchent la t\u00eate et le cou (\u223c90 %) sont du type carcinome spinocellulaire (aussi appel\u00e9 carcinome squameux, carcinome \u00e9pidermo\u00efde ou carcinome malpighien), et la plupart des patients (\u223c60 %) re\u00e7oivent [&hellip;]","og_url":"https:\/\/www.mdbriefcase.com\/fr\/cours\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/","og_site_name":"MDBriefCase","article_modified_time":"2024-12-19T21:38:01+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/","url":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/","name":"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures - MDBriefCase","isPartOf":{"@id":"https:\/\/www.mdbriefcase.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg","datePublished":"2024-06-03T20:14:34+00:00","dateModified":"2024-12-19T21:38:01+00:00","breadcrumb":{"@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#primaryimage","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/06\/Two-doctors-looking-at-x-ray-head-of-patient-8.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.mdbriefcase.com\/courses\/traitement-systemique-dans-les-carcinome-epidermoide-de-la-tete-et-du-cou-localement-avance-cetc-la-etat-actuel-et-directions-futures\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.mdbriefcase.com\/"},{"@type":"ListItem","position":2,"name":"Course","item":"https:\/\/www.mdbriefcase.com\/courses\/"},{"@type":"ListItem","position":3,"name":"Traitement syst\u00e9mique dans les carcinome \u00e9pidermo\u00efde de la t\u00eate et du cou localement avanc\u00e9 (CETC-LA) : \u00c9tat actuel et directions futures"}]},{"@type":"WebSite","@id":"https:\/\/www.mdbriefcase.com\/#website","url":"https:\/\/www.mdbriefcase.com\/","name":"MDBriefCase","description":"","publisher":{"@id":"https:\/\/www.mdbriefcase.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mdbriefcase.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.mdbriefcase.com\/#organization","name":"MDBriefCase","url":"https:\/\/www.mdbriefcase.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","contentUrl":"https:\/\/www.mdbriefcase.com\/wp-content\/uploads\/2024\/07\/logo.webp","width":190,"height":36,"caption":"MDBriefCase"},"image":{"@id":"https:\/\/www.mdbriefcase.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/205848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course"}],"about":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/types\/eb_course"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/comments?post=205848"}],"version-history":[{"count":0,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course\/205848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media\/526518"}],"wp:attachment":[{"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/media?parent=205848"}],"wp:term":[{"taxonomy":"eb_course_cat","embeddable":true,"href":"https:\/\/www.mdbriefcase.com\/fr\/wp-json\/wp\/v2\/eb_course_cat?post=205848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}